PF-56941 |
ACICLOVIR Balaxi 400 mg Tabletas recubiertas |
2024-07-12 |
|
Balaxi Healthcare Guatemala |
República de China
|
Impomed |
A R Pharma |
Repremedh Representaciones Médicas Hospitalarias |
Balaxi Healthcare Guatemala |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-56943 |
LORATADINA Balaxi 10 mg Tabletas recubiertas |
2024-07-12 |
|
Balaxi Healthcare Guatemala |
República de China
|
A R Pharma |
Repremedh Representaciones Médicas Hospitalarias |
Balaxi Healthcare Guatemala |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-48324 |
METAMIZOL Jiangsu 1g/2 mL Solución inyectable |
2018-02-18 |
|
Jiangsu Sihuan Bioengineering Co., Ltd. |
República de China
|
Promegal |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-55102 |
DIPYNAN 500 mg Tabletas |
2023-03-26 |
|
Balaxi Healthcare Guatemala |
República de China
|
Balaxi Healthcare Guatemala |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-56092 |
CALCIO Balaxi 600 mg Tabletas masticables |
2023-11-13 |
|
Balaxi Healthcare Guatemala |
República de China
|
Balaxi Healthcare Guatemala |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-56602 |
SULFATO FERROSO Balaxi 200 mg Grageas |
2024-04-22 |
|
Balaxi Healthcare Guatemala |
República de China
|
Balaxi Healthcare Guatemala |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-56684 |
HIDROCLOROTIAZIDA Balaxi 50 mg Tabletas |
2024-05-09 |
|
Balaxi Healthcare Guatemala |
República de China
|
Impomed |
A R Pharma |
Repremedh Representaciones Médicas Hospitalarias |
Balaxi Healthcare Guatemala |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-46017 |
AMIKACINA SULFATO Jinling 500 mg/2 mL Solución Inyectable |
2016-05-20 |
|
Jinling Pharmaceutical Co., Ltd. |
República de China
|
Italpharma |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-46859 |
SULFATO DE GENTAMICINA Jinling 40 mg/1 mL Solución Inyectable |
2017-01-31 |
|
Jinling Pharmaceutical Co., Ltd. |
República de China
|
Italpharma |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-54258 |
CEFALOTINA Jodas 1 g Polvo para uso parenteral |
2022-06-27 |
|
Jodas Expoim PVT.LTD. |
India
|
Coface Guatemala |
Bayco |
Droguería Colón |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|